Cocaine consumption has increased exponentially in Europe over the last few years. The European Drug Report for 2018 estimated that 17 million European adults had tried cocaine and 2.3 million young adults aged 15-34 had used the drug in the last year. The report’s findings indicated that Europe was experiencing the effects of an increase in South American cocaine production.
Cocaine is often cut with a variety of other ingredients that may make up to 80% of the substance sold. These can vary greatly from psychoactive, poisonous or anaesthetic ingredients to filler ingredients such as talc, flour or corn starch. Alexis Goosdeel, director of the EMCDDA stated that the European Drug Report’s findings were concerning. “We must be concerned about the health implications of cocaine use as we are beginning to see some worrying developments in this area, including a larger number of people entering treatment for the first time for cocaine problems,” he said. France saw an estimated 16,127 first-time entrants to treatment in 2016.
With the likelihood of street cocaine containing other, potentially fatal substances, it is paramount that medical professionals can act according to the needs of each patient. The main aspect of which is determining what they have consumed.
The application of the Evidence MultiSTAT
With the Evidence MultiSTAT’s extensive test menu. A wide variety of multiple drug classes can be screened on-site simultaneously with our CE marked urine and blood panels. As minimal sample preparation is required, qualitative results can be provided in 17 minutes, offering an efficient and accurate toxicology screen.